Clinical pharmacology of dacarbazine (DIC) following intensive corynbecterium parvum (CP) immunotherapy

S. W. Halll, R. S. Benjamin, J. U. Gutterman

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No.575
JournalProceedings of the American Association for Cancer Research
VolumeVol.18
StatePublished - 1977

ASJC Scopus subject areas

  • General Medicine

Cite this